Presented the exacerbation of COPD Management Protocol in hospitalización a domicilio.
within the framework of the Congress national of the society Spanish of hospitalization at home (SEHAD) ”.
-the manual as your coordinator, Dr Manuel Miron Rubio, is a useful tool to optimize resources and ensure that they are more efficient ” in the management of the disease
-Is, moreover, the first document that focuses specifically on both organizational and therapeutic procedures developed in hospitalización a domicilio (HaD)
Barcelona, June 2012.- this manual is a useful tool to optimize resources and achieve more efficient they ”, said the voyeur doctor Manuel Rubio, hospitalization service Chief to address of the Hospital of Torrejón, (Madrid) and coordinator of the Protocol of exacerbations of the disease pulmonary obstructive chronic (COPD) in hospital home care (HaD), which has been in the Congress national of the society Spanish of hospitalization at home (SEHAD) during the past weekend ” and who has counted with the support of the companies Pfizer and Boehringer Ingelheim.
As explained by the voyeur doctor Rubio, there are numerous guidelines and clinical practice guidelines on the management of COPD, but this document focuses specifically on both organizational and therapeutic procedures developed in HaD, since the admission of the patient at the time of the high ”. Also, one of the highlights of the Protocol ”, in whose elaboration involved both doctors and nursing staff, is that details the criteria for the proper selection of patients, as well as decision algorithms and recommendations on the use of other health care resources following discharge ”the voyeur doctor Rubio has clarified.
The manual, which includes general information about COPD, treatment, physiotherapy and respiratory rehabilitation, in the first part and has specifically HaD a second block dedicated to the management of the disease, is intended for medical professionals and nurses who carry out their medical activity in HaD. Torrejón hospital, who has also pointed out that it is of a manual utility for professionals in primary care, as various aspects of the continuum of care are ”.
About COPD
The COPD is a respiratory disease characterized by progressive and irreversible obstruction of the Airways that affects 1 of every 5 smokers in our country and is responsible for some 50 deaths a day (1). It is also a disease unknown and invisible for a large majority of the population and even for those affected to the extent that it is estimated that 73% of persons unknown that you suffer from (2).
COPD patients sometimes underestimate the initial symptoms until the disease is aggravated as a result of interpret them as something normal associated with their smoking consumption. Cough, the limitation on the exercise or the usual coughing does not have to be the smoker’s own symptoms but it can be an indication of the existence of this ailment.
About Boehringer Ingelheim provide value through innovation ”
The Group Boehringer Ingelheim figure among 20 of the world’s largest pharmaceutical companies. Headquartered in Ingelheim, Germany, works with 145 members in 50 countries and has more than 42,000 employees. Since its foundation in 1885, the independent family-owned company is committed to the research, development, production and marketing of new products of high therapeutic value for human medicine and animal.
Boehringer Ingelheim settled in Spain in 1952, and over the past 50 years has evolved to be ranked No. 10 of the pharmaceutical sector in our country. The company is headquartered in Spain in Sant Cugat del Vallès (Barcelona), and currently has more than 1,700 employees and two international centers of production. follow us on twitter by clicking here .
Pfizer, working together for a healthier world
founded in 1849, Pfizer is the largest biomedical company that promotes new initiatives to promote health. At Pfizer, we discover, develop and put to disposition, patient and professional health medicines effective, safe and quality, to treat and help prevent diseases, people and animals. Also, we work together with professionals and health authorities to ensure access to our medicines and to provide better health care and support to health systems. At Pfizer, all employees work every day to help people to have a healthier life and enjoy better quality of life.<? xml:namespace prefix = o ns = “urn: schemas-microsoft-com: Office” / >
follow us on Facebook by clicking here.
follow us on Twitter by clicking here.
follow us on YouTube by clicking here.
follow us on Flickr by clicking here.
follow us on Slideshare by clicking here.
–
referencia:
(1) National Epidemiology Centre . Instituto de Salud Carlos 11I, Ministry of science and innovation.
(2) M Miravitlles, Soriano JB, Garcia-rio F, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, J Ancochea. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009 Oct; 64 (10): 863-8.
